Reference : Rimonabant improves cardiometabolic risk factors in overweight/obese patients with poorl...

	Document type :	Scientific congresses and symposiums : Paper published in a journal
	Discipline(s) :	Human health sciences : Endocrinology, metabolism & nutrition
	To cite this reference:	http://hdl.handle.net/2268/7169

Title :	Rimonabant improves cardiometabolic risk factors in overweight/obese patients with poorly controlled type 2 diabetes (HbA(1c)>= 8%) on monotherapy with metformin or sulfonylureas
Language :	English
Author, co-author :	Scheen, André [Université de Liège - ULg > Département des sciences cliniques > Diabétologie, nutrition et maladie métaboliques - Médecine interne générale]
	Finer, N. [> > > >]
	Jensen, M. [> > > >]
	Hollander, P. [> > > >]
	Van Gaal, L. [> > > >]
Publication date :	Sep-2006
Journal title :	Diabetologia
Publisher :	Springer
Volume :	49
Issue/season :	Suppl. 1
Pages :	483-484
ISSN :	0012-186X
City :	New York
Permalink :	http://hdl.handle.net/2268/7169

	File(s) associated to this reference
	Fulltext file(s): File Commentary Version Size Access Open access Rimonabant improves cardiometabolic risk factors in.pdf Author postprint 29.51 kB View/Open

All documents in ORBi are protected by a user license.

 

© ULg Library Network |  Feedback |  ORBi legal notices

Dspace v1.5